A congressional map approved by Virginia voters that aims to help Democrats net four U.S. House seats in November’s midterms ...

Ocrelizumab shows the highest association with urinary tract infections in patients with MS according to an FDA Adverse Event ...

The Phase 2b trial has been designed to be statistically powered to evaluate key efficacy endpoints, including change from baseline in pain and physical function compared with placebo, measured at ...

University of California San Diego researchers have developed a new tool for understanding and modifying any microbiome, ...

Storm Therapeutics has closed a $56 million series C financing as the British biotech kicks off a phase 2 sarcoma trial of ...

Illinois’ new rental tax law prompts Jersey County to rethink Airbnb oversight ...

MS treatments during pregnancy do not seem to increase the risk of neurodevelopmental disorders in exposed children, a study ...

Just two months after the East Market Streetscape opened in NuLu, the bike track on the street's south side will be painted ...

Physical exercise may help reduce inflammation in MS by changing immune activity, a study in mice and patients suggests.

The government on Tuesday said that it is open to modifying the proposed IT rules amendments that propose to regulate user-generated news content on social media platforms such as YouTube, Instagram, ...

An enzyme replacement therapy developed by Immedica, the first drug for the inherited metabolic disorder arginase-1 (ARG1) deficiency that can alter the course of the disease, has been cleared for NHS ...

Amyloid-targeted monoclonal antibodies are the first disease-modifying therapies (DMTs) approved for Alzhemier’s disease (AD). Aducanumab received accelerated approval by the FDA but was not fully ...